Diabetes patients who took Ozempic were more than twice as likely to develop an eye condition that causes vision loss than patients using a different diabetes drug, according to a new study. Novo Nordisk, which manufactures Ozempic, says the findings don’t change the risk-benefit profile for Ozempic and similar drugs.

https://childrenshealthdefense.org/defender/ozempic-semaglutide-vision-loss-study-side-effects/?